<html><body><h2>Case: 2562132</h2><h3> CDS Time: 1970-05-22</h3>
<patient name=2562132>
70.0 year old Other_Race Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">70</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">101</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">3</td><td width="200">1969-11-10</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">30</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Chloride</td><td width="200">106.0</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">40</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">62</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">BNP</td><td width="200">6685.0</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Weight</td><td width="200">124</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">51</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">84</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">SGOT</td><td width="200">46</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">150</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Height</td><td width="200">62</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">84</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">BUN</td><td width="200">35</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">HCT</td><td width="200">30</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">HGB</td><td width="200">10</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Sodium</td><td width="200">139</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.0</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Pulse</td><td width="200">78</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">PLT</td><td width="200">117</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">WBC</td><td width="200">7</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">eGFR</td><td width="200">58</td><td width="200">1969-12-22</td></tr>
<tr><td width="200">SGPT</td><td width="200">45</td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1969-11-2</td></tr>
<tr><td width="200">smoking</td><td width="200"></td><td width="200">1969-12-6</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1969-12-9</td></tr>
<tr><td width="200">tobacco use</td><td width="200"></td><td width="200">1969-12-6</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">Other_Race</td><td width="200"></td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1969-11-11</td></tr>
<tr><td width="200">Pacemaker</td><td width="200"></td><td width="200">1969-11-5</td></tr>
<tr><td width="200">cardiac arrest</td><td width="200"></td><td width="200">1969-10-31</td></tr>
<tr><td width="200">Tobacco_Use</td><td width="200"></td><td width="200">1969-12-6</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1969-11-22</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1970-4-12</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1969-11-2</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) simvastatin(80.0) lisinopril(40.0) hydrochlorothiazide(25.0) lovastatin(40.0) furosemide(20.0) Insulin(0.04) amiodarone(800.0) bumetanide(6.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[Treatment_Systolic_BP(150/null) && Treatment_Diastolic_BP(62/null)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of myocardial infarction]()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension K >=3.5</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && Potassium(3.5/1970-4-12)]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null)]()</td></tr>
<tr><td width="200">MI_with_high_BP</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction[presence of MI && Treatment_Systolic_BP(150/null)]()</td></tr>
<tr><td width="200">On Amiodarone</td>
<td width="200"></td>
<td width="200"> Amiodarone[amiodarone]()</td></tr>
<tr><td width="200">ISH on HCTZ and BP not controlled</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && presence of HCTZ && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null)]()</td></tr>
<tr><td width="200">MI (BP not controlled)</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null) && presence of myocardial infarction]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(70.0/1970-1-1)]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(58.0/1969-12-22)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(58.0/1969-12-22)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(70.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Hypertension with MI and K>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(3.5/1970-4-12) && presence of MI]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1969-11-02</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-11-02</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-11-11</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-12-09</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-11-22</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr> <td width="200"></td>
<td width="200">1969-10-31</td>
<td width="200"> cardiac arrest()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1970-04-12</td>
<td width="200"> Hypertension()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(3.5/1970-4-12) && presence of MI]()</td></tr>
<tr><td width="200">Pacemaker</td>
<td width="200">1969-11-05</td>
<td width="200"> Pacemaker()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1969-12-06</td>
<td width="200"> Tobacco_Use()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(3.5/1970-4-12) && presence of MI]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1969-12-06</td>
<td width="200"> tobacco use()
<tr> <td width="200"></td>
<td width="200">1969-12-06</td>
<td width="200"> smoking()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">VA/JNC-VII Hypertension Guideline</h1>
<b>Patient classification:</b> <ul>
<li>VA/JNC-VII Hypertension Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(presence of diagnosis of hypertension && absence of renovascular disease && no diagnosis of pregnancy && Absense of Secondary Hypertension && absence of spinal cord injury && absence of narcolepsy && Not taking cyclosporine && Not taking spironolactone && Not taking minoxidil && absence of renovascular disease && absence of IHSS && Absence of Ascites && Not off guideline && not taking tacrolimus && absence of transplant recipient && Absence of a dialysis procedure code)</i>]
<li>Risk Group C (presence of TOD/CCD or DM): [because <i> presence of TOD/CCD or DM </i> evaluate to <b>true</b><i>(presence of TOD/CCD)</i>]
</ul>
<b>Scenario choice:</b> on two or three anti-hypertensive drugs
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Systolic_BP(150/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Recommendation</b>
<ul>
<li>It is true that 7.3 inches of rain fell yesterday, and the patient is taking the following drugs: Insulin, lisinopril, bumetanide, furosemide, hydrochlorothiazide, amiodarone
<li>The clinical information from this system is advisory only and is intended to supplement the knowledge of health care professionals regarding the management of hypertension. It is not intended to replace sound clinical judgment or individualized patient care in delivery of healthcare services.
  Although the ATHENA-HTN information is derived from research literature and is subject to review, we cannot guarantee its comprehensiveness or currency. Please note that medical information is dynamic due to ongoing research and clinical experience and is subject to interpretation. There is also the possibility of errors in the programming.  The user of this software assumes sole responsibility for any decisions made or actions taken based the information contained in this software, including but not limited to therapeutic suggestions.  ATHENA-HTN, the Department of Veterans Affairs and Stanford University shall have no liability to any person, or entity with regard to claims, loss, or damage caused, or alleged to be caused, directly or indirectly by the use of this software or the information contained within.  ATHENA-HTN is the property of Stanford's Office Technology Licensing (OTL) and Department of Veterans Affairs.  
By accessing ATHENA-HTN, you agree use ATHENA-HTN only as a reference resource for research. You agree to abstain from using ATHENA-HTN to generate knowledge for treatment.
</ul>
<li><b>Primary_Recommendation</b>
<ul>
<li>Consider INTENSIFYING drug treatment: BP ELEVATED based on most recent available BP; F/up 1month.
</ul>
<li><b>Assumption</b>
<ul>
<li>We did not find a BP in the vitals signs section of the computer.  We are not at present able to use the BP recorded in the text of the progress note, so we are not able to determine whether the BP control is adequate or inadequate.  Please enter BP using the top part of the screen.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>on medication: things to check</b><br>
<ul>
<li><b>assumption  check presence of BP <font color=FF0000>preferred</font></b>(rule in criterion<i> diastolic BP or systolic BP absent</i> evaluate to <b> true</b> because <i>absence of diastolic BP</i>)])
We did not find a BP in the vitals signs section of the computer.  We are not at present able to use the BP recorded in the text of the progress note, so we are not able to determine whether the BP control is adequate or inadequate.  Please enter BP using the top part of the screen.
<li><b>tobacco being used, encourage smoking cessation <font color=FF0000>preferred</font></b>(rule in criterion<i> tobacco use</i> evaluate to <b> true</b> because <i>tobacco use</i>)])
If patient is still smoking, please encourage smoking cessation
<li><b>risk group C message(on med), absence of DM <font color=FF0000>preferred</font></b>(rule in criterion<i> risk group C</i> evaluate to <b> true</b> because <i>risk group C</i>)])
This patient has clinically manifest cardiovascular disease or target organ damage (Risk Group C per JNC6).  The largest benefit of anti-hypertensive therapy is seen in patients with the highest baseline risk of cardiovascular disease, therefore this patient should be considered for prompt pharmacologic therapy, even if the BP is in the high-normal range.  Appropriate lifestyle modification and attention to other reversible cardiovascular risk factors is also strongly recommended.
<li><b>adverse event warning <font color=FF0000>preferred</font></b>(rule in criterion<i> presence of current medication with adverse reaction</i> evaluate to <b> true</b> because <i>presence of current medication with adverse reaction</i>)])
<li><b>test parameterized message <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
It is true that 7.3 inches of rain fell yesterday, and the patient is taking the following drugs: Insulin, lisinopril, bumetanide, furosemide, hydrochlorothiazide, amiodarone
<li><b>Disclaimer <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
The clinical information from this system is advisory only and is intended to supplement the knowledge of health care professionals regarding the management of hypertension. It is not intended to replace sound clinical judgment or individualized patient care in delivery of healthcare services.
  Although the ATHENA-HTN information is derived from research literature and is subject to review, we cannot guarantee its comprehensiveness or currency. Please note that medical information is dynamic due to ongoing research and clinical experience and is subject to interpretation. There is also the possibility of errors in the programming.  The user of this software assumes sole responsibility for any decisions made or actions taken based the information contained in this software, including but not limited to therapeutic suggestions.  ATHENA-HTN, the Department of Veterans Affairs and Stanford University shall have no liability to any person, or entity with regard to claims, loss, or damage caused, or alleged to be caused, directly or indirectly by the use of this software or the information contained within.  ATHENA-HTN is the property of Stanford's Office Technology Licensing (OTL) and Department of Veterans Affairs.  
By accessing ATHENA-HTN, you agree use ATHENA-HTN only as a reference resource for research. You agree to abstain from using ATHENA-HTN to generate knowledge for treatment.
</ul>
<li><b>two or three drug-therapy choices</b><br>
<ul>
<li><b>Blood pressure not adequately controlled. Intensify drug treatment <font color=FF0000>preferred</font></b>(strict rule-in condition<i> BP not adequately controlled based on most recent BP</i> evaluate to <b> true</b> because <i>BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null)</i>)])
Consider INTENSIFYING drug treatment: BP ELEVATED based on most recent available BP; F/up 1month.
</ul>
<li><b>step up choices</b><br>
<ul>
<li><b>evaluate new drug to prescribe <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>Cardioselective Beta Blocker (metoprolol)<ul><li>Drugs to partner:  Thiazide_Diuretics(hydrochlorothiazide) <li><font color=FF0000>Compelling indications:  Myocardial_Infarction(Myocardial_Infarction)  Heart_Failure(Cardiomegaly, Heart_Failure) </font><li>Relative indications:  Atrial_Fibrillation(Atrial_Fibrillation)  Coronary_Artery_Disease(Coronary_Artery_Disease)  CKD by eGFR or ICD9 codes(CKD[eGFR(58.0/1969-12-22)]) <li>Relative contraindications:  On Amiodarone(Amiodarone[amiodarone]) <li>amiodarone add beta blocker(Concurrent use of amiodarone and beta adrenergic receptor antagonist may result in excessive lowering of heart rate.)<li>add metoprolol, adjust dose other drugs(When adding metoprolol to this patient's therapeutic regime a dose adjustment of other anti-hypertensive drugs may be required.)<li>Atrial fibrillation and add NDHP orBB(Management of  arrythmia is complex and may require consultation with specialist.)<li>betablocker dyslipidemia warning message(Beta blockers may have transient adverse effects on lipids in some patients.  Consider repeating lipid profile after maximal dosage of drug has been reached if appropriate.)<li>disclaimer about procedure reports delete(Diagnoses from EKG reports are not extracted. If patient has an arrythmia that is not shown in patient summary, please update problem list.)<li>MI (BB)  and JNC7 rec aldosterone antag(Beta Adrenergic Receptor Antagonist is compellingly indicated for post MI by JNC7 and 2004 VA Guidelines, JNC7 also has aldosterone antagonists as a compelling indication for MI.)<li>preference: preferred</ul><li>Angiotensin II Receptor Blocker (irbesartan)<ul><li>Drugs with bad interactions:  ACE_Inhibitors(lisinopril) <li><font color=FF0000>Compelling indications:  CKD by eGFR or ICD9 codes(CKD[eGFR(58.0/1969-12-22)]) </font><li>Relative indications:  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>DHP Calcium Channel Blocker (felodipine, nifedipine SA)<ul><li>Relative indications:  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null) && presence of myocardial infarction]) <li>preference: preferred</ul><li>(non-DHP) Calcium Channel Blocker (diltiazem)<ul><li>Relative indications:  Atrial_Fibrillation(Atrial_Fibrillation)  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null) && presence of myocardial infarction])  CKD by eGFR or ICD9 codes(CKD[eGFR(58.0/1969-12-22)]) <li>Relative contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure)  On Amiodarone(Amiodarone[amiodarone]) <li>Amiodarone add diltiazem('Concurrent use of amiodarone and diltiazem may result in excessive lowering of heart rate.)<li>heart failure and ndhp(Patient has heart failure which is a relative contraindication to diltiazem. Evaluate potential benefit versus harm of initiating diltiazem. Follow clinically.)<li>HF + MI consider felodipine(Felodipine is the preferred CCB because it has less myocardial effects than diltiazen.)<li>Atrial fibrillation and add NDHP orBB(Management of  arrythmia is complex and may require consultation with specialist.)<li>disclaimer about procedure reports delete(Diagnoses from EKG reports are not extracted. If patient has an arrythmia that is not shown in patient summary, please update problem list.)<li>preference: preferred</ul><li>Potassium Sparing Diuretic <ul><li>preference: neutral<li>No comment</ul><li>Alpha Blocker (terazosin)<ul><li>preference: neutral<li>No comment</ul><li>ACE Inhibitor (lisinopril)<ul><li>Already being used<li><font color=FF0000>Compelling indications:  Heart_Failure(Cardiomegaly, Heart_Failure)  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null) && presence of myocardial infarction])  CKD by eGFR or ICD9 codes(CKD[eGFR(58.0/1969-12-22)]) </font><li>preference: ruled out</ul><li>Thiazide Diuretic (HCTZ)<ul><li>Already being used<li>Drugs with bad interactions:  furosemide(furosemide) <li><font color=FF0000>Compelling indications:  CKD by eGFR or ICD9 codes(CKD[eGFR(58.0/1969-12-22)])  taking >= 2 anti hypertensive meds(Combination therapy for HTN[Antihypertensive_Agents]) </font><li>Relative indications:  MI (BP not controlled)(Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(150/null) && presence of myocardial infarction]) <li>preference: ruled out</ul></ul></body></html>